Advertisement

Topics

FDA Renews and Expands Its Portfolio of Simcyp Simulator (PBPK) Licenses

08:00 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Increased Use of Physiologically-based Pharmacokinetic (PBPK) Modeling and Simulation (M&S) is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments Certara®, the global leader in mo...

Other Sources for this Article

Certara
Ellen Leinfuss, 609-216-9586
Chief Commercial Officer
or
Rana Healthcare Solutions
Lisa Osborne, 206-992-5245
lisa@ranahealth.com

NEXT ARTICLE

More From BioPortfolio on "FDA Renews and Expands Its Portfolio of Simcyp Simulator (PBPK) Licenses"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...